Ellen brings a unique blend of scientific expertise and strategic thinking to her role as Managing Director at Cadent Medical Communications. Throughout her career in medical education and healthcare advertising, she has amassed significant experience developing strategic communication platforms for numerous educational and promotional initiatives, including peer-to-peer, medical affairs and publications.  She relishes in learning new science and working with her team and clients to bring it to life for the HCP audience.
 
Ellen’s scientific repertoire spans numerous therapeutic categories across accounts both domestic and global. She has worked extensively in the fields of oncology (immunotherapy, prostate cancer, hepatocellular carcinoma, renal cell carcinoma, CML, oncology diagnostics, and oncology supportive care), dermatology (psoriasis), gastroenterology (IBD [ulcerative colitis and Crohn’s disease]) rheumatology/immunology (lupus, osteoarthritis, and rheumatoid arthritis), respiratory (COPD), neurology (TTR-FAP and movement disorders), as well as cardiology (anticoagulation) and diabetes (SGLT2 inhibition), supporting products and brands from development to launch and lifecycle management.
 
Prior to joining Cadent in 2017, Ellen was SVP, Director Medical and Scientific Services at The Bloc and prior to that worked at Ogilvy Healthworld. She received her doctorate degree in cancer biology from Columbia University where she was the recipient of the Rover Award for Outstanding Graduate Student Achievement. Ellen’s work has been published in several peer-reviewed journals.